Unicycive Therapeutics, Inc. (UNCY) posted FY 2025 basic and diluted EPS of -$1.67.
Unicycive Therapeutics, Inc. is a Biotechnology company. Bottom line showed a net loss of $26.6M.
Wall Street consensus stands at 10 buy, 1 hold, 0 sell.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.